Tag: Quarterly Results

Business Healthcare & Pharmaceuticals News

Eli Lilly Reports Strong Q2 2025 Financial Results with 38% Revenue Growth

Eli Lilly and Company

Eli Lilly and Company reported strong second-quarter 2025 financial results, with worldwide revenue increasing 38% to $15.56 billion. This growth was driven by a 42% increase in volume, particularly from the company’s key products Zepbound and Mounjaro. Reported earnings per share (EPS) for the quarter were $6.29, a 92% increase compared to the same period in 2024. Following these results, Lilly has raised its full-year 2025 revenue guidance to a range of $60.0 billion to $62.0 billion.

Business News

Pfizer Reports Strong Q2 2025 Results, Raises Full-Year EPS Guidance

pfizer news

Pfizer delivered robust Q2 2025 results, reporting $14.7 billion in revenue (up 10% operationally) and $0.78 adjusted EPS. Key drivers included double-digit growth from Comirnaty, Paxlovid and Abrysvo. The company raised its full-year adjusted EPS guidance to $2.90–3.10 while reaffirming revenue outlook of $61.0–64.0 billion, underscoring strong commercial execution and cost-saving initiatives.

Business Healthcare & Pharmaceuticals News

Johnson & Johnson Beats Q2 Estimates, Raises 2025 Outlook on Strong Sales Growth

JohnsonAndJohnson

Johnson & Johnson announced robust second-quarter 2025 financial results, surpassing analyst expectations and raising its full-year guidance. The healthcare giant reported a significant 5.8% increase in sales to $23.7 billion, driven by strong performances in its Innovative Medicine and MedTech segments.